Two cancer research studies reveal essential role of neutrophils in immunotherapy

Two independent Ludwig Cancer Research studies published in the current issue of the journal Cell show that immune cells known as neutrophils, whose abundance in the microenvironment of tumors has traditionally been associated with poor patient prognosis, can play an important role in the success of cancer immunotherapies.

ASCO 2023: Immunotherapy for brain cancer metastases shows

WCLC 2023: Benmelstobart plus anlotinib and chemotherapy shows

Researchers uncover potential biomarkers of positive response to

Turbocharging the killing power of immune cells against cancer

MicroRNA specifically kills cancer cells with common mutation

Stress-tolerant cells drive tumour initiation in pancreatic cancer

ESMO 2016: Ceritinib provides longer PFS than chemo in trial of

Results from the TAGS study demonstrate safety and efficacy of

Positive opinion for orphan drug designation for avelumab in

WCLC 2022: Sugemalimab a safe and effective consolidation therapy